174 related articles for article (PubMed ID: 8570224)
1. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
Zariwala M; Liu E; Xiong Y
Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
[TBL] [Abstract][Full Text] [Related]
2. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
Zariwala M; Xiong Y
Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
4. Expression of CDK inhibitor genes in immortalized and carcinoma derived breast cell lines.
Zhou JN; Linder S
Anticancer Res; 1996; 16(4A):1931-5. PubMed ID: 8712723
[TBL] [Abstract][Full Text] [Related]
5. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
Stone S; Dayananth P; Jiang P; Weaver-Feldhaus JM; Tavtigian SV; Cannon-Albright L; Kamb A
Oncogene; 1995 Sep; 11(5):987-91. PubMed ID: 7675459
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
7. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
Noh SJ; Li Y; Xiong Y; Guan KL
Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
[TBL] [Abstract][Full Text] [Related]
8. A p18 mutant defective in CDK6 binding in human breast cancer cells.
Lapointe J; Lachance Y; Labrie Y; Labrie C
Cancer Res; 1996 Oct; 56(20):4586-9. PubMed ID: 8840966
[TBL] [Abstract][Full Text] [Related]
9. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A
Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
12. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
Suzuki T; Narita T; Uchida-Toita M; Yoshida M
Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662
[TBL] [Abstract][Full Text] [Related]
14. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer.
Blais A; Labrie Y; Pouliot F; Lachance Y; Labrie C
Biochem Biophys Res Commun; 1998 Jun; 247(1):146-53. PubMed ID: 9636670
[TBL] [Abstract][Full Text] [Related]
15. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
Zindy F; Quelle DE; Roussel MF; Sherr CJ
Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355
[TBL] [Abstract][Full Text] [Related]
16. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
Knapek DF; Serrano M; Beach D; Trono D; Walker CL
Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
[TBL] [Abstract][Full Text] [Related]
18. The COOH terminus of p18INK4C distinguishes function from p16INK4A.
Gump J; Turner S; Koh J
Cancer Res; 2001 May; 61(10):3863-8. PubMed ID: 11358797
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M
Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
